Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04075864 · ClinicalTrials.gov registry record · NA

Feasibility of a New Model for Exercise Prescription in Cystic Fibrosis

A NA study, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
3
Enrollment target

NCT04075864: Completed NA study, sponsored by University of Alabama at Birmingham.

NCT04075864 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04075864, a NA study, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
3 participants
Enrollment target

Study Summary

The purpose of this protocol is to begin an exercise program combined with behavioral counseling for patients who are hospitalized with a cystic fibrosis exacerbation. The exercise program will begin during the hospital stay. Beginning an exercise program during this period of reduced mobility and isolation may be an ideal time to deliver a structured exercise prescription along with a behavioral program to promote long-term adherence to exercise (structured physical activity) . Hospitalized patients have an acute awareness that their lung function is declining and may be more motivated and open to changing their behavior and adding exercise to their treatment regimen.

Primary Outcome

forced expiratory volume in 1 second

Interventions

  • BEHAVIORAL Behavioral Counseling and Exercise

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2020-12-01
Est. Completion 2025-12-10
Phase NA
University of Alabama at Birmingham

1,160 total trials

What the finished NCT04075864 record still lists

NCT04075864 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which Behavioral Counseling and Exercise is the first listed.

NCT04075864 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04075864 about?

NCT04075864 is a clinical study titled "Feasibility of a New Model for Exercise Prescription in Cystic Fibrosis". The purpose of this protocol is to begin an exercise program combined with behavioral counseling for patients who are hospitalized with a cystic fibrosis exacerbation. The exercise program will begin during the hospital stay. Beginning an exercise program during this period of reduced mobility and i...

What is the current status of trial NCT04075864?

This trial is currently completed. It is a NA study. The enrollment target is 3 participants. The study started on 2020-12-01. Estimated completion is 2025-12-10.

What interventions are being tested in trial NCT04075864?

The interventions under investigation include: Behavioral Counseling and Exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT04075864?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04075864's enrollment target sits among peer trials

3 1996th of 2000 higher than 4 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04075864, the US trial registry maintained by the National Library of Medicine. NCT04075864 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.